Friday, March 14, 2025
spot_img

Copa Holdings Announces Monthly Traffic Statistics for February 2025

PANAMA CITY, March 13, 2025 (GLOBE NEWSWIRE) — Copa Holdings, S.A. (NYSE: CPA) today released preliminary passenger traffic statistics for February 2025:

Operating Data February
2025
February
2024
% Change
Copa Holdings (Consolidated)      
ASM (mm) (1) 2,389.9   2,348.8   1.7 %
RPM (mm) (2) 2,072.0   2,025.8   2.3 %
Load Factor (3) 86.7%   86.3%   0.4 p.p.
  1. Available seat miles – represents the aircraft seating capacity multiplied by the number of miles the seats are flown.
  2. Revenue passenger miles – represents the number of miles flown by revenue passengers
  3. Load factor – represents the percentage of aircraft seating capacity that is actually utilized
  4. February 2024: 29 days

For February 2025, Copa Holdings’ capacity (ASMs) increased by 1.7%, while system-wide passenger traffic (RPMs) increased by 2.3%, compared to 2024. As a result, the system load factor for the month was 86.7%, 0.4 percentage points higher than in February 2024.

Copa Holdings is a leading Latin American provider of passenger and cargo services. The Company, through its operating subsidiaries, provides service to countries in North, Central, and South America and the Caribbean. For more information visit www.copaair.com.

CPA-G

CONTACT: Daniel Tapia – Panamá
Director – Investor Relations
011 (507) 304-2774

Powered by SlickText.com

Hot this week

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Topics

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Parsons to Present at the Bank of America Global Industrials Conference

CHANTILLY, Va., March 13, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img